FDA Authorizes REGEN-COV for Post-Exposure Prophylaxis for COVID-19

The FDA revised the EUA for casirivimab and imdevimab, the Regeneron cocktail for post-exposure prophylaxis (PEP) ...

AUGUST 3, 2021